Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

North Little Rock, Arkansas Clinical Trials

A listing of North Little Rock, Arkansas clinical trials actively recruiting patient volunteers.

RESULTS

Found (5) clinical trials

A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)

This is a Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of antolimab (AK002), given monthly for 6 doses, in patients with moderately to severely active Eosinophilic Gastritis and/or Eosinophilic Duodenitis (formerly referred to as Eosinophilic Gastroenteritis) who have an inadequate response with, lost response ...

Phase

4.63 miles

Learn More »

A Study of Antolimab (AK002) in Patients With Active Eosinophilic Esophagitis

This is a Phase 2/3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of antolimab (AK002) given monthly for 6 doses in adult and adolescent patients with active eosinophilic esophagitis. Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of ...

Phase

5.15 miles

Learn More »

Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder

The study will enroll approximately 375 subjects randomized 1:1:1 to dose regimens of 180g, 120g BXCL501, or placebo stratified by age < 65 and age 65. Male and female adults with acute agitation associated with bipolar disorder will be enrolled. Eligible subjects (acutely agitated subjects with bipolar disorder, generally hypomanic, ...

Phase

8.62 miles

Learn More »

A Clinical Study to Evaluate the Safety and Efficacy of the Optilume BPH Catheter System in Men With Symptomatic BPH

PINNACLE is a prospective, multi-center, randomized control clinical trial to establish the safety and efficacy of the Optilume BPH Catheter System in the treatment of benign prostatic hyperplasia (BPH)

Phase N/A

8.62 miles

Learn More »